Myriad Genetics, Inc.’s recent filing unveils that its Director SPIEGELMAN DANIEL K unloaded Company’s shares for reported $83525.0 on Jun 04 ’24. In the deal valued at $22.05 per share,3,788 shares were sold. As a result of this transaction, SPIEGELMAN DANIEL K now holds 32,917 shares worth roughly $0.93 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, SPIEGELMAN DANIEL K sold 3,788 shares, generating $83,488 in total proceeds. Upon selling the shares at $22.04, the Director now owns 36,705 shares.
Before that, DIAZ PAUL J sold 95,000 shares. Myriad Genetics, Inc. shares valued at $2,394,798 were divested by the President and CEO at a price of $25.21 per share. As a result of the transaction, DIAZ PAUL J now holds 1,141,166 shares, worth roughly $32.16 million.
Scotiabank initiated its Myriad Genetics, Inc. [MYGN] rating to a Sector outperform in a research note published on June 27, 2024; the price target was $29. Leerink Partners also remained covering MYGN and has increased its forecast on May 08, 2024 with a “an Outperform” recommendation from previously “Market perform” rating.
Price Performance Review of MYGN
On Friday, Myriad Genetics, Inc. [NASDAQ:MYGN] saw its stock jump 1.18% to $28.18. Over the last five days, the stock has gained 0.82%. Myriad Genetics, Inc. shares have risen nearly 47.23% since the year began. Nevertheless, the stocks have risen 66.84% over the past one year. While a 52-week high of $28.90 was reached on 07/24/24, a 52-week low of $13.82 was recorded on 01/08/24. SMA at 50 days reached $25.77, while 200 days put it at $21.90.
Levels Of Support And Resistance For MYGN Stock
The 24-hour chart illustrates a support level at 27.82, which if violated will result in even more drops to 27.46. On the upside, there is a resistance level at 28.43. A further resistance level may holdings at 28.68. The Relative Strength Index (RSI) on the 14-day chart is 61.00, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.46, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 17.88%. Stochastics%K at 74.56% indicates the stock is a holding.
How much short interest is there in Myriad Genetics, Inc.?
A steep rise in short interest was recorded in Myriad Genetics, Inc. stocks on 2024-07-31, dropping by -0.22 million shares to a total of 4.39 million shares. Yahoo Finance data shows the prior-month short interest on 2024-06-28 was 4.61 million shares. There was a decline of -5.1%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on December 19, 2023 when Wells Fargo began covering the stock and recommended ‘”an Equal weight”‘ rating along with a $20 price target.
